Wockhardt informs about press release

03 Apr 2017 Evaluate

Wockhardt has informed about Press Release titled ‘Wockhardt receives acknowledgement of its breakthrough superdrug Antibiotic WCK 5222 for Phase III Clinical Trial from US FDA’.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

549.10 11.05 (2.05%)
14-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.25
Dr. Reddys Lab 5861.00
Cipla 1356.95
Zydus Lifesciences 984.75
Lupin 1635.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.